Clinical Trial

Mitochondrial Function and Metabolomic Profile in Alzheimer's Disease and Related Dementias

Study acronym: AMPAlz
Recruiting
View on ClinicalTrials.gov →
Summary
This project aims to study on one hand the early mitochondrial alterations, common or specific, occurring in peripheral cells of patients with Alzheimer's disease or related dementia and, on the other hand, identify the metabolomic biomarkers that may be at the origin of mitochondrial disturbances associated with the disease. This will be the first study combining functional analyses of mitochondria and exploratory metabolomic assessments in the same cohort at early stages of the disease.
Protocol Amendment History 4 amendments
This ClinicalTrials.gov record has been amended 4 times since 2025-03-11; most recent amendment 2026-06-16.
Status change: Not Yet Recruiting → Recruiting 2025-03-31
Trial Details
NCT Number NCT06880406
Lead Sponsor Centre Hospitalier Universitaire de Nice
Conditions Alzheimer Disease
Enrollment 250 participants
Start Date 2025-07-01
Primary Completion 2028-07-01 (estimated)
Study Completion 2029-04-01 (estimated)
Updated on ClinicalTrials.gov 2026-06-18